Home › Bile Duct Cancer (Cholangiocarcinoma) › California
Pag-aaral pangklinika para sa Bile Duct Cancer (Cholangiocarcinoma) sa California
20 pag-aaral para sa Bile Duct Cancer (Cholangiocarcinoma) ang naghahanap ng mga kalahok sa mga site sa California.
Mga Lungsod sa California
- Los Angeles7 pag-aaral
- Mountain View5 pag-aaral
- Baldwin Park5 pag-aaral
- Orange4 pag-aaral
- San Francisco3 pag-aaral
- Santa Monica3 pag-aaral
Opisyal na teksto ng pag-aaral (English)
A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06840886A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer
- City of Hope (Site 107), Duarte
- University of California at Irvine (Site 101), Orange
- UCLA Medical Center (Site 117), Santa Monica
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07265674A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- START Los Angeles, Los Angeles
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07488676Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- Stanford University, Palo Alto
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT05732831Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 31, 2026 · NCT05497531AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 20, 2026 · NCT07619313Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- UCI Irvine Health, Orange
Nagre-recruitPhase 4
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT07486713Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
- City of Hope Medical Center, Duarte
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05285358A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Precision NextGen Oncology & Research Center, Beverly Hills
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
- University of California Los Angeles Rheumatology, Westwood, Los Angeles
Nagre-recruitPhase 2
Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
- USC Norris Comprehensive Cancer Center, Los Angeles
- LACN Aneheim Flagship Office, Los Angeles
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05874414A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- USC Norris Comprehensive Cancer Center, Los Angeles
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07337525A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- City of Hope Nat Medical Ctr, Duarte
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT07224750An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- City of Hope Medical Center, Duarte
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 7, 2026 · NCT06342414A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT07169734Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
- University of California, Davis Comprehensive Cancer Center, Sacramento
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 2, 2026 · NCT06101277A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Cedars-Sinai Medical Center, Los Angeles
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT07458347A Study of MGC028 in Participants With Advanced Solid Tumors
- UCSF - Helen Diller Family Cancer Center, San Francisco
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT06723236REGULUS: MRI-guided Adaptive SABR for Liver Cancers
- Stanford University, Palo Alto
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT07223307SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Duarte
- Massive Bio SYNERGY-AI site, Irvine
- Massive Bio SYNERGY-AI site, La Jolla
- at 3 pa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.